Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schuster

Showing results (421-430 of 630) with videos related to

Pageof 63
Sort By:
Blood Advances|September 8, 2023
Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphomaSamuel Yamshon, Gui Zhen Chen, Caitlin Gribbin, et al.
Journal of Hematology & Oncology|November 4, 2017
Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)Michael Wang, Stephen J Schuster, Tycel Phillips, et al.
Radiology|May 1, 1991
Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imagingE S Siegelman, D G Mitchell, R Rubin, et al.
Microbiome|January 25, 2022
Enhanced IgA coating of bacteria in women with Lactobacillus crispatus-dominated vaginal microbiotaAnnelot C Breedveld, Heleen J Schuster, Robin van Houdt, et al.
Cancer Biology & Therapy|December 14, 2007
Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and managementAnthony R Mato, Alicia K Morgans, Michele R Roullet, et al.
Transplantation|May 26, 2001
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patientsD E Tsai, C L Hardy, J E Tomaszewski, et al.
Cancer Medicine|November 18, 2021
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trialSriram Balasubramanian, Brendan Hodkinson, Stephen J Schuster, et al.
International Archives of Occupational and Environmental Health|June 16, 2022
Working conditions in low risk nulliparous women in The Netherlands: are legislation and guidelines a guarantee for a healthy working environment? A cohort studyMonique D M van Beukering, Heleen J Schuster, Myrthe J C S Peelen, et al.
Molecular Psychiatry|September 20, 2017
An in vitro model of lissencephaly: expanding the role of DCX during neurogenesisM Shahsavani, R J Pronk, R Falk, et al.
The New England Journal of Medicine|November 5, 2015
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell LymphomaJia Ruan, Peter Martin, Bijal Shah, et al.
Pageof 63

Showing results (421-430 of 630) with videos related to

Sort By:
Pageof 63
Blood Advances|September 8, 2023
Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphomaSamuel Yamshon, Gui Zhen Chen, Caitlin Gribbin, et al.
Journal of Hematology & Oncology|November 4, 2017
Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)Michael Wang, Stephen J Schuster, Tycel Phillips, et al.
Radiology|May 1, 1991
Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imagingE S Siegelman, D G Mitchell, R Rubin, et al.
Microbiome|January 25, 2022
Enhanced IgA coating of bacteria in women with Lactobacillus crispatus-dominated vaginal microbiotaAnnelot C Breedveld, Heleen J Schuster, Robin van Houdt, et al.
Cancer Biology & Therapy|December 14, 2007
Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and managementAnthony R Mato, Alicia K Morgans, Michele R Roullet, et al.
Transplantation|May 26, 2001
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patientsD E Tsai, C L Hardy, J E Tomaszewski, et al.
Cancer Medicine|November 18, 2021
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trialSriram Balasubramanian, Brendan Hodkinson, Stephen J Schuster, et al.
International Archives of Occupational and Environmental Health|June 16, 2022
Working conditions in low risk nulliparous women in The Netherlands: are legislation and guidelines a guarantee for a healthy working environment? A cohort studyMonique D M van Beukering, Heleen J Schuster, Myrthe J C S Peelen, et al.
Molecular Psychiatry|September 20, 2017
An in vitro model of lissencephaly: expanding the role of DCX during neurogenesisM Shahsavani, R J Pronk, R Falk, et al.
The New England Journal of Medicine|November 5, 2015
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell LymphomaJia Ruan, Peter Martin, Bijal Shah, et al.
Pageof 63